Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Bepler

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Molecular & Cellular Proteomics : MCP|July 31, 2008
Proteomic contributions to personalized cancer careJohn M Koomen, Eric B Haura, Gerold Bepler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Cell Death & Disease|May 9, 2020
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53Chen Hu, Mu Zhang, Niko Moses, et al.
The Journal of Biological Chemistry|October 4, 2013
Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migrationKendra A Williams, Mu Zhang, Shengyan Xiang, et al.
NAR Cancer|January 16, 2023
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastropheJoshua R Heyza, Elmira Ekinci, Jacob Lindquist, et al.
Oncogene|June 6, 2003
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerRafael Rosell, Giorgio Scagliotti, Kathleen D Danenberg, et al.
Cancer|February 25, 2020
Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors studyJennifer L Beebe-Dimmer, Julie J Ruterbusch, Felicity W K Harper, et al.
Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Iscience|March 27, 2023
Identification of actionable targets for breast cancer intervention using a diversity outbred mouse modelJennifer B Jacob, Kuang-Chung Wei, Gerold Bepler, et al.
Journal of Oncology Practice|March 2, 2012
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in FloridaTawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Molecular & Cellular Proteomics : MCP|July 31, 2008
Proteomic contributions to personalized cancer careJohn M Koomen, Eric B Haura, Gerold Bepler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Cell Death & Disease|May 9, 2020
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53Chen Hu, Mu Zhang, Niko Moses, et al.
The Journal of Biological Chemistry|October 4, 2013
Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migrationKendra A Williams, Mu Zhang, Shengyan Xiang, et al.
NAR Cancer|January 16, 2023
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastropheJoshua R Heyza, Elmira Ekinci, Jacob Lindquist, et al.
Oncogene|June 6, 2003
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerRafael Rosell, Giorgio Scagliotti, Kathleen D Danenberg, et al.
Cancer|February 25, 2020
Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors studyJennifer L Beebe-Dimmer, Julie J Ruterbusch, Felicity W K Harper, et al.
Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Iscience|March 27, 2023
Identification of actionable targets for breast cancer intervention using a diversity outbred mouse modelJennifer B Jacob, Kuang-Chung Wei, Gerold Bepler, et al.
Journal of Oncology Practice|March 2, 2012
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in FloridaTawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, et al.
Pageof 16